Gut Bacteria on COVID Severity
Coronavirus disease 2019 (COVID-19) has affected millions of lives globally. However, the disease has presented more extreme challenges for developing countries that are experiencing economic crises. Studies on COVID-19 symptoms and gut health are scarce and have not fully analyzed possible associations between gut health and disease pathophysiology. Therefore, this study aimed to demonstrate a potential association between gut health and COVID-19 severity in the Lebanese community, which has been experiencing a severe economic crisis.
Related Conference of Gut Bacteria on COVID Severity
January 18-19, 2027
22nd International Conference on Virology, Emerging Diseases & vaccines
London, UK
February 15-16, 2027
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Tokyo, Japan
April 01-02, 2027
22nd International Conference on Microbial Interactions & Microbial Ecology
Madrid, Spain
August 25-26, 2027
13th International Congress on Trauma, Critical Care and Emergency Medicine
Paris, France
Gut Bacteria on COVID Severity Conference Speakers
Recommended Sessions
- Microbiome
- Pediatric and Infant Health
- Pre and Probiotics futures
- Prebiotics and Diet
- Prebiotics old and new
- Probiotics in Aquaculture
- Probiotics in food security
- Synbiotic
- Food and Fermentation
- Formulations and Production
- Gut Bacteria on COVID Severity
- Gut microbiota
- Microbiota from womb to adult
- Microbiota Protection and Resilience
- New Methods and New Equipment
- Nutrition and Probiotics
- Preterm and term Newborns Probiotics
- Probiotics and COVID-19
- Probiotics in oral health and dentistry
- Probiotics in women’s health
Related Journals
Are you interested in
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Critical Care Medicine - TRAUMA 2027 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2027 (France)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2027 (France)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Global Health and Trauma Care - TRAUMA 2027 (France)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric and Neonatal Emergency Care - TRAUMA 2027 (France)
- Resuscitation and Emergency Response - TRAUMA 2027 (France)
- Trauma and Emergency Medicine - TRAUMA 2027 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2027 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2027 (France)
